Stonegate Capital Partners Updates Coverage on Incannex Healthcare Inc. (NasdaqGM: IXHL) 2Q26
Incannex continued to build the clinical and patient-reported evidence base for IHL-42X in obstructive sleep apnea (OSA), following full Phase 2 RePOSA data and exit-interview analyses. Both lowand high-dose IHL-42X achieved statistically significant reductions in ApneaHypopnoea Index (AHI) versus placebo, with maximum AHI reductions of up to 83% in the high-dose arm. Exit interviews showed […]
Stonegate Capital Partners Updates Coverage on Materion Corp (NYSE: MTRN) 4Q25
Materion’s 4Q25 results underscored strong structural tailwinds across its portfolio, even as the Company worked through a temporary precision clad strip quality issue. Management highlighted accelerating semiconductor demand – particularly outside China – driven by AI, high-performance computing, and data storage, which supports a favorable mix and expands margins in Electronic Materials. Defense remains a […]
Stonegate Capital Partners Updates Coverage on Nu Skin Enterprises Inc. (NYSE: NUS) 4Q25
NUS reported revenue, adj NI, and adj EPS of $370.3M, $14.5M, and $0.29, respectively. This compares to our estimates of $380.2M, $15.1M, and $0.30, respectively. These results were at the low end of revenue guidance and the high end of EPS guidance. Rhyz delivered $48.52M of revenue, including $42.45M from Manufacturing and $6.07M from Rhyz […]
Stonegate Capital Partners Updates Coverage on Burcon Nutrascience Corporation (TSX: BU) 3Q26
Burcon’s Galesburg production facility represents a pivotal transition from development-stage operations to commercial scale, with 3Q26 revenue of $739,000 reflecting approximately 107% quarter-overquarter growth driven by protein sales and production activity at the site. Notably, the Company entered CY2025 without a production facility and exited the year meeting its revenue target, underscoring the speed of […]
Stonegate Capital Partners Updates Coverage on Civeo Corporation (NYSE: CVEO) 3Q25
CVEO reported revenue and adj EBITDA of $170.5M and $28.8M, respectively. This compares to our/consensus estimates of $175.9M/$173.5M and $27.7M/$27.8M, respectively. The year-over-year EBITDA increase reflected continued strength in Australia and the benefit of cost-cutting initiatives in Canada. Operating cash flow totaled $13.8M, while capital expenditures were $5.6M, primarily related to maintenance of lodges and […]
Stonegate Capital Partners Updates Coverage on Materion Corp (NYSE: MTRN) 3Q25
Materion’s 3Q25 results reflected another quarter of disciplined execution and margin resilience despite temporary operational headwinds. The Company delivered year-over-year growth in revenue and value-added sales, underpinned by record profitability in Electronic Materials and continued transformation in Precision Optics. Strength in semiconductor demand—particularly outside China—along with improving defense and energy sales, offset softness in automotive […]
Stonegate Capital Partners Updates Coverage on Third Coast Bancshares Inc. (NYSE: TCBX) 4Q25
For 4Q25, Third Coast reported net income of $17.9M, compared to $18.1M in 3Q25 and $13.7M in 4Q24, equal to basic and diluted EPS of $1.21 and $1.02, respectively. The modest Q/Q decline was primarily driven by merger-related legal/professional expenses and higher salaries/benefits, partially offset by higher NII and an increase in non-margin loan fees. […]
Stonegate Capital Partners Updates Coverage On Franklin Covey Co (NYSE: FC) 1Q26
Franklin Covey delivered performance in-line with expectations with very strong underlying metrics during 1Q as the Company returns to growth for FY26. Ultimately, we view the current situation as the leading edge of an acceleration, noting that the new go-to market strategy is resulting in strong logo growth, diligent cost cutting is expected to compound, […]
Stonegate Capital Partners Updates Coverage Initiates Report on Viemed Healthcare Inc. (NASDAQ: VMD)
Viemed Healthcare is the leading U.S. provider of in-home post-acute respiratory care, specializing in non-invasive ventilation (“NIV”) for patients with COPD and chronic respiratory failure. The Company delivers care through a clinician-driven, high-touch model that integrates respiratory therapists, proprietary clinical workflows, and continuous patient monitoring to improve outcomes and reduce total cost of care. While […]
Stonegate Capital Partners Updates Coverage on Hooker Furniture Corporation (NASDAQ: HOFT) 3Q26
HOFT reported revenue, operating income, and adj EPS of $70.7M, ($16.3)M, and ($1.99), respectively. This compares to our/consensus estimates of $85.2M/$85.5M, ($2.2)M/($2.2)M, and ($0.15)/($0.14). Revenues came in below expectations, declining 32.2% y/y, driven primarily by the Company selling the majority of it’s HMI business segment. In contrast, Hooker Branded net sales grew 4.4% y/y and […]